Back
Genting Singapore Ltd. Vs. Travere Therapeutics, Inc. Industry Stock Comparison
Sell
48
GIGNY
Genting Singapore Ltd.
Last Price:
$28.41
Seasonality Move:
9.17%
Buy
78
TVTX
Travere Therapeutics, Inc.
Last Price:
$39.6600
Seasonality Move:
33.23%
Sell
48
Genting Singapore Ltd. (GIGNY)
is a Sell
Is Genting Singapore Ltd. a Buy, Sell or Hold?
-
The current Genting Singapore Ltd. [GIGNY] share price is $28.41. The Score for GIGNY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
GIGNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
78
Travere Therapeutics, Inc. (TVTX)
is a Buy
Is Travere Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Travere Therapeutics, Inc. [TVTX] share price is $39.6400. The Score for TVTX is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GIGNY Stock Price Chart
What is Genting Singapore Ltd.'s stock price today?
-
The Genting Singapore Ltd. share price today is $28.41Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GIGNY is experiencing slight buying pressure.
TVTX Stock Price Chart
What is Travere Therapeutics, Inc.'s stock price today?
-
The Travere Therapeutics, Inc. share price today is $39.6400Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight selling pressure.
GIGNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.45 | Sell |
| Relative Strength Index (14 RSI): | 51.98 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.86 - 30.54) | Sell |
| Bollinger Bands (100): | (27.36 - 30.84) | Sell |
TVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.28 | Buy |
| Relative Strength Index (14 RSI): | 66.31 | Buy |
| Chaikin Money Flow: | -583105 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.9202 - 36.9202) | Buy |
| Bollinger Bands (100): | (20.9405 - 34.5405) | Buy |
GIGNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.32 | Buy |
| 20-day SMA: | 27.94 | Buy |
| 50-day SMA: | 28.31 | Buy |
| 200-day SMA: | 28.52 | Sell |
| 8-day EMA: | 27.48 | Buy |
| 20-day EMA: | 27.98 | Buy |
| 50-day EMA: | 28.02 | Buy |
| 200-day EMA: | 18.82 | Buy |
TVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.31 | Buy |
| 20-day SMA: | 35.4 | Buy |
| 50-day SMA: | 33.69 | Buy |
| 200-day SMA: | 22.3 | Buy |
| 8-day EMA: | 30.99 | Buy |
| 20-day EMA: | 18.54 | Buy |
| 50-day EMA: | 8.93 | Buy |
| 200-day EMA: | 2.46 | Buy |
Genting Singapore Ltd. Earnings Growth & GIGNY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.
Genting Singapore Ltd. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Travere Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||